Skip to search formSkip to main contentSkip to account menu

Tegafur

Known as: 1-(Tetrahydro-2-furanyl)-5-fluorouracil, Tegafur [Chemical/Ingredient], 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione 
A congener of the antimetabolite fluorouracil with antineoplastic activity. Tegafur is a prodrug that is gradually converted to fluorouracil in the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
A prospective randomized trial was conducted to evaluate the efficacy of long-term oral administration of low-dose tegafur… 
1995
1995
In order to find out whether the response rate and survival in epithelial ovarian cancer can be improved by aid of sensitivity… 
1984
1984
The cardiotoxic and neurotoxic effects of tegafur, an anticancer agent, were compared with those of uracil plus tegafur (4:1 mol… 
Highly Cited
1983
Highly Cited
1983
A total of 65 patients with advanced colorectal or breast cancer were given oral tegafur in the phase I study. Of these, 28… 
1983
1983
A phase I clinical study of tegafur (ftorafur) was conducted in 29 patients with various advanced solid tumors. To evaluate its… 
1980
1980
The antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) on sarcoma was enhanced by oral coadministration of… 
1978
1978
A photosensitive lichen planus-like eruption developed in a 63-year-old man during postoperative chemotherapy with 1-(2… 
1978
1978
Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil (HCFU) against Lewis lung carcinoma and B16 melanoma by long-term oral… 
1976
1976
Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil against various tumors was examined. Therapeutic ratio (ILSmax/ILS30) in L…